A Robust Portfolio of Cancer Clinical Trials
Adult Clinical Trials
View all active adult clinical trials available through the Froedtert & the Medical College of Wisconsin Cancer Network.
Pediatric Clinical Trials
Learn about pediatric clinical trials, where research is conducted, and find a doctor.
Physician Referrals
Visit MCW Physician ACCESS (All Cancer Center Enrolling Studies) to locate a potential match for adult and pediatric patients.
A Leader in Cancer Clinical Trials
The MCW Cancer Center is recognized by the National Cancer Institute as a Lead Academic Participating Site for its scientific leadership, the strength and innovation of its research and science, and robust participation in National Clinical Trials Network clinical trials. The Center is one of only 32 institutions in the United States to achieve this designation, and the only institution in Milwaukee and the eastern Wisconsin region.
Translational Research Units
The Froedtert & MCW Cancer Network is one of a few cancer care networks in the nation with two dedicated cancer translational research units and has the only cancer inpatient translational research unit in Wisconsin. These translational research units focus on early-phase clinical trials that are conducted among a small numbers of patients. Early-phase clinical trials are essential to evaluating promising new therapies that may lead to FDA approval as standard treatment of care.
The Importance of Clinical Trials
Eradicating cancer means investigating how cancer impacts everyone – and discovering treatments for all types of patients. MCW Cancer Center investigators (the physicians and researchers producing clinical trials) collect more reliable data when more people participate in a clinical trial. The more patients who qualify, the greater the chances the study will reflect the outcomes of the real-world population that will eventually use the new therapy.
If you’re eligible for a clinical trial and decide that’s the next best step for you, we’ll work to ensure you have the support needed to participate.
Translational Research Unit Celebrates 10 Years of Accelerating Novel Cancer Therapies
Froedtert and the MCW Cancer Center recently celebrated the 10th anniversary of the Nicholas Family Foundation Translational Research Unit (TRU), the state-of-the-art clinical and research facility that has been instrumental in accelerating novel ideas and launching practice-changing cancer clinical trials.
Beyond the Beam: How MCW Innovators are Transforming Radiation Therapy with Sonoptima
The first-of-its-kind wearable device uses AI and ultrasound to monitor bladder fullness in real time, helping patients with pelvic cancers know exactly when to start radiation treatment.
Every Day Counts Study Improves Life for Women with Metastatic Breast Cancer
The 16-week lifestyle intervention aims to understand what happens when women with breast cancer make small, manageable changes to how they eat, move, and manage their health.
PROTECT-PANC Trial Evaluates Precision Medicine Strategies in Patients with Pancreatic Cancer
The fast-track trial bolsters MCW’s dedication to advancing precision medicine strategies across a spectrum of cancer types.
Clinical Trial Identifies New Therapy for Graft Versus Host Disease
MCW Cancer Center scientists identify new therapy to reduce the severity of gastrointestinal graft versus host disease and improve patient outcomes.